Inhibition of complement C1s by sutimlimab (SUT) in patients with cold agglutinin disease (CAD): results on efficacy and safety from the randomized, placebo-controlled phase 3 CADENZA study (NCT03347422)

被引：0

作者：

Roeth, A. ^{[1
]}

Berentsen, S. ^{[2
]}

Barcellini, W. ^{[3
]}

D'Sa, S. ^{[4
]}

Jilma, B. ^{[5
]}

Michel, M. ^{[6
]}

Weitz, I. C. ^{[7
]}

Yamaguchi, M. ^{[8
]}

Nishimura, J. -i ^{[9
]}

Vos, J. M. ^{[10
,11
]}

Storek, M. ^{[12
]}

Wong, N. W. ^{[12
]}

Patel, P. ^{[12
]}

Jiang, X. ^{[12
]}

Vagge, D. ^{[13
]}

Wardecki, M. ^{[14
]}

Shafer, F. ^{[12
]}

Lee, M. ^{[12
]}

Broome, C. M. ^{[15
]}

机构：

[1] Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, West German Canc Ctr, Essen, Germany

[2] Haugesund Hosp, Dept Res & Innovat, Haugesund, Norway

[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[4] Univ Coll London Hosp NHS Fdn Trust, UCLH Ctr Waldenstroms Macroglobulinemia & Related, London, England

[5] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria

[6] UPEC, Henri Mondor Univ Hosp, Assistance Publ Hop Paris, Creteil, France

[7] USC, Keck Sch Med, Jane Anne Nohl Div Hematol, Dept Med, Los Angeles, CA USA

[8] Ishikawa Prefectural Cent Hosp, Dept Hematol, Kanazawa, Japan

[9] Osaka Univ, Osaka, Japan

[10] Amsterdam UMC, Amsterdam, Netherlands

[11] Sanquin, Dept Hematol, Amsterdam, Netherlands

[12] Sanofi, Cambridge, England

[13] IQVIA, Bangalore, Karnataka, India

[14] Sanofi, Warsaw, Poland

[15] MedStar Georgetown Univ Hosp, Div Hematol, Washington, DC USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 2期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V575

引用

页码：172 / 173

页数：2

共 50 条

[41] Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study
Tadashi Terui
Yukari Okubo
Satomi Kobayashi
Shigetoshi Sano
Akimichi Morita
Shinichi Imafuku
Yayoi Tada
Masatoshi Abe
Masafumi Yaguchi
Natsuka Uehara
Takahiro Handa
Masayuki Tanaka
Wendy Zhang
Maria Paris
Masamoto Murakami
American Journal of Clinical Dermatology, 2024, 25 : 165 - 167
[42] Efficacy and safety of anamorelin HCl in NSCLC patients: Results from a randomized, double-blind, placebo-controlled, multicenter phase II study
Temel, J.
Bondarde, S.
Jain, M.
Allen, S.
Mann, W.
EUROPEAN JOURNAL OF CANCER, 2013, 49 : S269 - S270
[43] EFFICACY AND SAFETY OF INCOBOTULINUMTOXINA IN THE TREATMENT OF UPPER FACIAL LINES: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY
Kerscher, Martina
Rzany, Berthold
Prager, Welf
Trevidic, Patrick
Inglefield, Christopher
TOXICON, 2018, 156 : S60 - S60
[44] Efficacy and Safety of Linaclotide in Patients With IBS-C: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial in China and Other Regions
Yang, Yunsheng
Fang, Jing-Yuan
Guo, Xiaozhong
Dai, Ning
Shen, Xizhong
Yang, Youlin
Sun, Jing
Reasner, David S.
Johnston, Jeffrey
Zeng, Peter
Lim, Sam
GASTROENTEROLOGY, 2016, 150 (04) : S741 - S741
[45] Teriflunomide Efficacy and Safety in Patients with Relapsing Multiple Sclerosis: Results from TOWER, a Second, Pivotal, Phase 3 Placebo-Controlled Study
Miller, Aaron
Kappos, Ludwig
Comi, Giancarlo
Confavreux, Christian
Freedman, Mark
Olsson, Tomas
Wolinsky, Jerry
Bagulho, Teresa
Delhay, Jean-Luc
Zheng, Yan
Truffinet, Philippe
O'Connor, Paul
NEUROLOGY, 2013, 80
[46] Efficacy and Safety of Brodalumab In Patients With Moderate To Severe Plaque Psoriasis: Results of AMAGINE-1, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
Papp, K.
Reich, K.
Blauvelt, A.
Baran, W.
Bolduc, C.
Toth, D.
Gottlieb, A. B.
Thaci, D.
Li, J.
Nirula, A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
[47] Efficacy and safety of brodalumab in patients with moderate to severe plaque psoriasis: Results of AMAGINE-1, a phase 3, randomized, double-Blind, placebo-controlled study
Papp, Kim
Reich, Kristian
Leonardi, Craig
Paul, Carle
Blauvelt, Andrew
Baran, Wojciech
Bolduc, Chantal
Toth, Darryl
Langley, Richard G.
Cather, Jennifer
Gottlieb, Alice
Thaci, Diamant
Milmont, Cassandra E.
Lim, Joanne
Klekotka, Paul
Kricorian, Greg
Nirula, Ajay
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
[48] EFFICACY AND SAFETY OF ODEVIXIBAT IN PATIENTS WITH ALAGILLE SYNDROME: TOP-LINE RESULTS FROM ASSERT, A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
Ovchinsky, Nadia
Aumar, Madeleine
Baker, Alastair
Baumann, Ulrich
Bufler, Philip
Cananzi, Mara
Czubkowski, Piotr
Durmaz, Ozlem
Fischer, Ryan
Indolfi, Giuseppe
Karnsakul, Wikrom
Lee, Florence Lacaille Way S.
Maggiore, Giuseppe
Rosenthal, Philip
Ruiz, Mathias
Sokal, Etienne
Sturm, Ekkehard
Van der Woerd, Wendy
Verkade, Henkjan J.
Wehrman, Andrew
Clemson, Christine
Yu, Qifeng
Ni, Quanhong
Ruvido, Jessica
Manganaro, Susan
Mattsson, Jan P.
HEPATOLOGY, 2023, 77 (05) : E121 - E121
[49] Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study
Cai, L.
Gu, J.
Zheng, J.
Zheng, M.
Wang, G.
Xi, L. -Y.
Hao, F.
Liu, X. -M.
Sun, Q. -N.
Wang, Y.
Lai, W.
Fang, H.
Tu, Y. -T.
Sun, Q.
Chen, J.
Gao, X. -H.
Gu, Y.
Teixeira, H. D.
Zhang, J. -Z.
Okun, M. M.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (01) : 89 - 95
[50] Efficacy and Safety of Tocilizumab in Patients with Refractory Takayasu Arteritis: Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial in Japan
Nakaoka, Yoshikazu
Isobe, Mitsuaki
Takei, Syuji
Tanaka, Yoshiya
Ishii, Tomonori
Yokota, Shumpei
Nomura, Akira
Yoshida, Seitaro
Nishimoto, Norihiro
ARTHRITIS & RHEUMATOLOGY, 2016, 68

← 1 2 3 4 5 →